How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

We have updated our Privacy Policy. Please review to learn more. By continuing to use our services, you agree to these updates. Chinese-made DJI drones are “like ...

Buying pharmaceutical stocks gives investors exposure to the global pharmaceutical market. This market totals roughly $2 trillion and continues to grow. The huge sector improves the quality of life ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...